2021 annual financial data
Elicio Therapeutics 2021 Operating cash flow
Direct answer
Operating cash flow was -23,939,045 USD.
Operating income was -39,307,000 USD and net income was -26,400,698 USD.
Operating cash flow was -23,939,045 USD.
Get free Elicio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 28,312,000 USD
- Operating income
- -39,307,000 USD
- Net income
- -26,400,698 USD
- Operating cash flow
- -23,939,045 USD